Labour pain. Delivery
Conditions
Interventions
Intervention 1: Control group:In this group placebo, normal saline will be given intravenous to pregnant lady in active labour stage with 3-4 cm cervical dilation and main primary outcomes that is pai
1000 mg of acetaminophenin 100ml of normal saline. Secondary outcomes that are duration of labour, Apgar score measured by Apgar scale, complications during deliver
Sponsors
Public sector medical college Rawalpindi Pakistan
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Primigravida of 18–35 year. Full-term with uncomplicated spontaneous onset of labour at term (37–42 weeks gestation). Singleton pregnancy. Cervical dilatation of 3-5 cm. Cephalic presentation of fetus.
Exclusion criteria
Exclusion criteria: Malpresentation of fetus. Multiparous women. Previously scarred uterus (post myomectomy, post cesarean). Preterm labour. Antepartum hemorrhage. History of drug allergy or hypersensitivity. Fetal distress (abnormal foetal monitoring during labour). Intrauterine foetal death. Refusal by parturient. History of alcohol/drug abuse. Systemic and local sepsis. Deranged coagulation profile. Obstetric complications (e.g., premature rupture of amniotic membranes). Women with clinical evidence of cephalopelvic disproportion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain assessment. Timepoint: After first dose of paracetamol in Group A and placebo in Group B administration pain will be measured at 15 minutes, 30 minutes, and then at hourly intervals till 4 hours and then readminister the second dose of paracetamol and placebo and then will measure outcome at 15 minutes, 30 minutes, and then at hourly intervals till 4 hours. Method of measurement: Visual Analogue Scale to measure pain.;Body mass index. Timepoint: At the start of intervention. Method of measurement: Weight by weighing machine in kgs and height in feet by scale.;Pulse rate. Timepoint: Before intervention and one time in middle of 4 hours after intervention of first dose and second dose. Method of measurement: Heart rate monitor (HRM).;Blood pressure. Timepoint: Before intervention and one time in middle of 4 hours after intervention of first dose and second dose. Method of measurement: Sphygmomonometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of labour. Timepoint: Duration of first stage of labour, duration of second stage, total duration of labour. Method of measurement: Clock to measure time of first and second stage of labour and total duration of labour.;Complications during delivery. Timepoint: During three stages of labour. Method of measurement: Health care provider will measure using clinical findings.;Side-effects after intervention: Nausea, vomiting, sedation, dizziness. Timepoint: During three stages of labour. Method of measurement: Health care provider will measure using clinical findings.;APGAR. Timepoint: At 1 min and 5 min. Method of measurement: APGAR scale. | — |
Countries
Pakistan
Contacts
Public ContactWajeha najeeb
Public sector medical college Rawalpindi Pakistan
Outcome results
None listed